Prosfin – 5 mg Tablet/pcs

৳  10.04

In stock

Generic Name: Finsteride
Therapeutic class: BPH Products (Drugs for Urinary Incontinence)
Manufacturer: Beximco Pharmaceuticals Ltd

Note: চিকিৎসকের পরামর্শ মোতাবেক  ঔষধ সেবন করুন




Finasteride is indicated for the treatment and control of benign prostatic hyperplasia (BPH)-

  • To cause regression of the enlarged prostate
  • To improve urinary flow
  • To improve the symptoms associated with BPH.

Dosage & Administration

The recommended dosage is one 5 mg tablet daily. Although early improvement may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. Thereafter, treatment should be continued.

Side Effects

Finasteride is well tolerated. In clinical studies, the following adverse experiences have been reported as possibly drug related in 1% of patients treated for 12 months with 5 mg Finasteride daily: impotence (3.7%), decreased libido (3.3%), and decreased volume of ejaculate (2.8%).

Pregnancy & Lactation

Finasteride is contra-indicated in women who are or may become pregnant. Finasteride is not indicated for use in women. It is not known whether finasteride is excreted in human milk.

Exposure to finasteride- risk to male fetus: Crushed or broken Finasteride Tablets should not be handled by women who are or may become pregnant because of the possibility of absorption of finasteride and the subsequent potential risk to a male fetus. Similarly, small amounts of finasteride have been recovered from the semen in subjects receiving Finasteride 5 mg/day. It is not known whether a male fetus may be adversely affected if his mother is exposed to the semen of a patient being treated with finasteride. Therefore, when the patients sexual partner is or may become pregnant, the patient should either avoid exposure of his partner to semen (e.g. by use of a condom) or discontinue Finasteride

Precautions & Warnings

General: Since the beneficial response to Finasteride may not be manifested immediately, patients with large residual urine volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy.

Prostate cancer: Digital rectal examination, as well as, other evaluations for prostate cancer, should be performed on patients with BPH prior to initiating therapy with Finasteride and periodically thereafter. Finasteride causes a decrease in serum concentration of markers of prostatic cancer such as prostate specific antigen (PSA); therefore, reduction of serum levels of these markers in patients with BPH treated with Finasteride does not rule out concomitant prostate cancer. No clinical benefit has yet been demonstrated in patients with prostate cancer treated with Finasteride.

Use in Special Populations

Renal insufficiency: Dosage adjustments are not necessary in patients with renal insufficiency since pharmacokinetic studies did not indicate any change in the disposition of Finasteride.

Hepatic insufficiency: There are no data available in patients with hepatic insufficiency.

Elderly: No dosage adjustment is required in elderly patients.

Therapeutic Class

BPH/ Urinary retention/ Urinary incontinence

Storage Conditions

Store at 20-25° C. Protect from light.

* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন


Only logged in customers who have purchased this product may leave a review.


There are no reviews yet.

See It Styled On Instagram

    No access token

Main Menu

Prosfin - 5 mg Tablet( Beximco )

Prosfin - 5 mg Tablet/pcs

৳  10.04

Add to cart